Previous close | 26.13 |
Open | 26.22 |
Bid | 26.15 x 28400 |
Ask | 26.16 x 2100 |
Day's range | 26.08 - 26.41 |
52-week range | 24.96 - 53.80 |
Volume | |
Avg. volume | 3,603,803 |
Market cap | 25.695B |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.17 |
Earnings date | 06 Aug 2024 |
Forward dividend & yield | 0.11 (0.42%) |
Ex-dividend date | 29 Apr 2024 |
1y target est | 33.80 |
A Pennsylvania judge on Tuesday drastically reduced a $2.25 billion verdict against Bayer AG (OTC:BAYRY), cutting it down to $400 million in a case involving a man who claimed he developed cancer from using the company’s Roundup weedkiller. The jury in the Philadelphia Court of Common Pleas had initially awarded John McKivison $250 million in compensatory damages and $2 billion in punitive damages, finding that his non-Hodgkin’s lymphoma was caused by long-term use of Roundup at his home. Howeve
NEW YORK (Reuters) -A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller. A jury in the Philadelphia Court of Common Pleas found that John McKivison's non-Hodgkins lymphoma was the result of using Roundup for yard work at his house for several years, and it ordered Bayer to pay $250 million in compensatory damages and $2 billion in punitive damages. Judge Susan Schulman granted some of Bayer's post-trial motions challenging that verdict, reducing compensatory damages to $50 million and punitive damages to $350 million.
Insight into Herro's Latest Portfolio Adjustments and Key Stock Performances